Skip to content

Homoeopathic treatment of tear in anal canal

Double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in improving symptoms of chronic anal fissure in adults

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050632
Enrollment
111
Registered
2023-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K601- Chronic anal fissure

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies(cH
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases suffering from chronic anal fissure ICD-10(K60.1), with symptoms persisting for more than 6 weeks. 2. Participants of either sex or transgender. 3. Age between 18 and 65 years. 4. Literate patient; ability to read and write in Bengali and/or English. Illiterate participants will be interviewed by the investigators maintaining adequate privacy to fill up the scale or questionnaires 5. Patients with known but controlled systemic diseases. 6. Patients using topical agents for anal fissure will be included after a washout period of one week, subject to persistence of symptoms and signs of fissures. 7. Patients giving written consent voluntarily to participate.

Exclusion criteria

Exclusion criteria: 1.Cases suffering from uncontrolled systemic illness or life-threatening infections. 2. Cases already undergoing homoeopathic treatment elsewhere for any chronic purpose within last 6 months. 3. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 4. Previous history of surgical interventions for anal fissure. 5. Diagnosed or suspected cases of rectal malignancies. 6. Pregnancy, puerperium and lactation. 7. Patients with psychiatric diseases. 8. Secondary fissure. 9. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. 10. Simultaneous participation of any other clinical trial

Design outcomes

Primary

MeasureTime frame
The scoring system for anal fissure (REALISE)Timepoint: At baseline, every 15 days, up to 3 months

Secondary

MeasureTime frame
Anorectal symptom severity and quality of life questionnaire (ARSSQoL) Measure yourself medical outcome proile (MYMOP-2) Timepoint: Every month, every 15 days, up to 3 months

Countries

India

Contacts

Public ContactSoumya Bhattacharyya

D N De Homoeopathic Medical College and Hospital

soumya.bh@gmail.com9836998171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026